Schubert & Co’s Repligen RGEN Stock Holding History

Schubert & Co’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13	Closed	-$2.19K	–	1182
2023 Q1	$2.19K	Hold	13	–	–	﹤0.01%	873
2022 Q4	$2.2K	Sell	13 -4	-24%	-$726	﹤0.01%	821
2022 Q3	$3K	Buy	17 +5	+42%	+$1.05K	﹤0.01%	664
2022 Q2	$2K	Buy	12 +6	+100%	+$949	﹤0.01%	865
2022 Q1	$1K	Buy	6 +1	+20%	+$190	﹤0.01%	880
2021 Q4	$1K	Buy	+5	New	+$1.35K	﹤0.01%	825

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Schubert & Co's RGEN Position: Q2 2023 in Review

Schubert & Co sold out of Repligen (RGEN) in Q2 2023, closing a stake of 13 shares — an estimated $2.19K sold.

Schubert & Co first reported a position in RGEN in Q4 2021 and held it in 6 quarters. The position peaked at $3K in Q3 2022. 446 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

Schubert & Co reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 13 Repligen shares in Q2 2023, an estimated $2.19K.
Schubert & Co first reported a position in Repligen in Q4 2021 and held it in 6 quarters.
Schubert & Co's Repligen position peaked at $3K in Q3 2022.
446 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.